TREt-Kras(G12D)-PGK-rtTA3
(Plasmid
#256624)
-
PurposeAn "All-in-One" Sleeping Beauty (SB) transposon vector for doxycycline-inducible expression of oncogenic Kras(G12D).
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 256624 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneSB pT2 B/H
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert 1
-
Gene/Insert nameKras
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)567
-
MutationG12D
-
Entrez GeneKras (a.k.a. K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2, c-K-ras, c-Ki-ras, p21B, ras)
- Promoter Ef1a
Cloning Information for Gene/Insert 1
- Cloning method Gibson Cloning
- 5′ sequencing primer TAATACGACTCACTATAGG
- (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namerTertR
-
Insert Size (bp)747
- Promoter PGK
Cloning Information for Gene/Insert 2
- Cloning method Gibson Cloning
- 5′ sequencing primer TAATACGACTCACTATAGG
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
TREt-Kras(G12D)-PGK-rtTA3 was a gift from Wen Xue (Addgene plasmid # 256624 ; http://n2t.net/addgene:256624 ; RRID:Addgene_256624) -
For your References section:
KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression. Qiao Y, Yee MF, Parikh CN, Ma B, Cao Y, Shih YH, Wu JQ, Ruscetti M, Liang SQ, Xue W. Adv Sci (Weinh). 2026 Jan;13(6):e11312. doi: 10.1002/advs.202511312. Epub 2025 Dec 3. 10.1002/advs.202511312 PubMed 41332325